HSCS Stock Summary and Trading Ideas (Heartsciences | NASDAQ:HSCS)

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

Heartsciences trades on the NASDAQ stock market under the symbol HSCS.

As of April 2, 2026, HSCS stock price declined to $2.30 with 15,058 million shares trading.

HSCS has a beta of 1.48, meaning it tends to be more sensitive to market movements. HSCS has a correlation of 0.11 to the broad based SPY ETF.

HSCS has a market cap of $7.32 million. This is considered a Sub-Micro Cap stock.

Last quarter Heartsciences reported $0 in Revenue and -$.63 earnings per share. This fell short of revenue expectation by $-200,000 and exceeded earnings estimates by $.49.

In the last 3 years, HSCS traded as high as $149.00 and as low as $2.01.

The top ETF exchange traded funds that HSCS belongs to (by Net Assets): VXF.

HSCS has underperformed the market in the last year with a price return of -16.4% while the SPY ETF gained +18.2%. HSCS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -25.6% and -10.9%, respectively, while the SPY returned -3.6% and -0.6%, respectively.

HSCS support price is $2.22 and resistance is $2.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HSCS shares will trade within this expected range on the day.